A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Recruiting now · Phase 1/Phase 2
Conditions studied: mCRPC (Metastatic Castration-resistant Prostate Cancer), Prostate Cancer
In brief
This is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with darolutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)
Key facts
- Study ID
- NCT06785636
- Run by
- Pathos AI, Inc.
- People needed
- 120
- Starts
- 2025-02-07
- Expected to finish
- 2029-04-30
- Last updated by the study team
- 2026-06-10
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- MemorialCare Orange Coast Medical Center — Fountain Valley, California, United States (enrolling)
- Cancer and Blood Research Center — Los Alamitos, California, United States (enrolling)
- University of Colorado Health — Aurora, Colorado, United States (enrolling)
- Mount Sinai Medical Center — Miami, Florida, United States (enrolling)
- Emory University Hospital — Atlanta, Georgia, United States (enrolling)
- University of Chicago — Chicago, Illinois, United States (enrolling)
- Community Health Network — Indianapolis, Indiana, United States (enrolling)
- Ochsner — Jefferson, Louisiana, United States (enrolling)
- Johns Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
- Karmanos Cancer Institute — Detroit, Michigan, United States (enrolling)
- Siteman Cancer Center — St Louis, Missouri, United States (enrolling)
- Nebraska Cancer Specialists — Omaha, Nebraska, United States (enrolling)
- Duke University medical center — Durham, North Carolina, United States (enrolling)
- The Ohio State University — Columbus, Ohio, United States (enrolling)
- Taylor Cancer Research Center — Maumee, Ohio, United States (enrolling)
- University of Texas Southwestern Medical Center — Dallas, Texas, United States (enrolling)
- Oncology Consultants, P.A — Houston, Texas, United States (enrolling)
- NEXT Oncology - Virginia — Fairfax, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.